Unit Dose Nasal Spray
Product Description
Grünenthal GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
Categories
Specifications
Grünenthal GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
More Products from Grünenthal GmbH (8)
-
Product Biopharma Assembly and Packaging
Biopharma Assembly and Packaging Services
We offer top yield rates, high flexibility and exceptional quality standards in assembly and packaging of pre-filled syringes (PFS), pre-filled pens (PFP) in all batch sizes via manual, semi-manual and automated technologies. -
Product Sterile Ampoule Filling/Packaging
Sterile Ampoule Filling/Packaging -
Product Integrated Manufacturing Services
Integrated Manufacturing Services -
Product Wallet Packaging
We are also highly experienced in the handing of controlled substances.
-
Product Tramadol HCl
Grünenthal GmbH offers a selected range of products which includes Tramadol HCl, as API, bulk and/ or finished dosage form. Please contact us for more information.
-
Product Betahistine 12.5 mg/ml Oral Drops
Glass bottle containing 100 ml oral solution with disposal pump. -
Product Betahistine diHCl
Grünenthal GmbH offers a selected range of products which includes Betahistine diHCl, as API, bulk tablets and/ or finished dosage form. Please contact us for more information.
-
Product Calcium carbonate + vit D3
Calcium carbonate + vit D3 tablets
Grünenthal GmbH resources (2)
-
News Grünenthal Responsability Report 2025/2026
Responsibility at Grünenthal goes beyond policies and numbers. It is reflected in how we act every day – guided by our vision of a World Free of Pain and a clear ambition to create positive change over and above our core business. This report shows how our people bring this commitment to life, through real-world examples, authentic voices and tangible achievements from across Grünenthal. -
News Grünenthal Report 2025/2026
At Grünenthal, our teams are driving progress toward our vision of a World Free of Pain. Guided by a clear strategy, we have transformed the company to position it for long-term success. Since 2017, this transformation has delivered sustainable growth, a diversified portfolio and a strong innovation pipeline to improve patient care, while fostering a culture that attracts international talent.


.png)



